Amit Garg, MD, FAAD
SESSIONS
S008 Update in General Dermatology
Mar 27, 2026
•
9:00 AM - 12:00 PM
•
Four Seasons 3
S030 A New Paradigm in the Management of the Hidradenitis Suppurativa Disease Spectrum
Mar 28, 2026
•
9:00 AM - 12:00 PM
•
Mile High 2B
U051 Acne and Hidradenitis Suppurativa: Clinical and Pathogenetic Correlations
Mar 28, 2026
•
4:30 PM - 5:30 PM
•
Bluebird 1A
F058 How to Approach Challenges in Hidradenitis Suppurativa Management: Strategies to Optimize Use of HS Therapies
Mar 29, 2026
•
1:00 PM - 3:00 PM
•
Bluebird 1B
DISCLOSURES
AbbVie – Advisory Board(Honoraria); Almirall – Consultant (1099 relationship)(Fees); Incyte Corporation – Advisory Board(Honoraria); Insmed Incorporated – Consultant (1099 relationship)(Honoraria); Novartis – Consultant(Honoraria); Pfizer Inc. – Investigator(Grants/Research Funding); Sanofi – Data Safety Monitoring Board(Fees); Sun Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Fees); UCB – Consultant(Honoraria); Zura Bio – Consultant (1099 relationship)(Fees);